• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ORGANON & CO. JADA SYSTEM; INTRAUTERINE VACUUM CONTRACTION SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ORGANON & CO. JADA SYSTEM; INTRAUTERINE VACUUM CONTRACTION SYSTEM Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Insufficient Information (4580)
Event Date 10/01/2022
Event Type  Injury  
Event Description
Unable to place the jada system appropriately assuming it to be due to user error so it could not be utilized [device placement issue].Did the jada device stop control the bleeding? no [device ineffective].Case narrative: this initial spontaneous report originating from united states, was received from a physician via customer account specialist (cas) referring to a female patient of unknown age.The patient's medical history included pregnancy, caesarean section, and delivery (discrepant information provided: "it was reported that patient was currently pregnant").The patient's concomitant medications, and drug reactions/allergies were not reported.This report concerns 1 patient and 1 device.Approximately on an unknown date in october 2022 (reported as sometime last month), the patient underwent vacuum-induced hemorrhage control system (jada system) placement for post-partum hemorrhaging (postpartum haemorrhage) (lot# was not reported).The vacuum-induced hemorrhage control system (jada system) was unable to be placed appropriately assuming it to be due to user error so it could not be utilized (device placement issue).It was reported that vacuum-induced hemorrhage control system (jada system) did not stop controlling the bleeding (device ineffective).After the removal of the vacuum-induced hemorrhage control system (jada system) the patient was taken to the operating room where a bakri balloon was placed and then the patient went to interventional radiology.The reporting physician was not the health care provider (hcp) who had inserted the vacuum-induced hemorrhage control system (jada system).It was reported that it was believed that vacuum-induced hemorrhage control system (jada system) came with a blue seal valve kit and green carton since the place at which patient underwent vacuum-induced hemorrhage control system (jada system) placement ran out of the white seal valve and carton back in june.It was reported that maternal admission to intensive care unit (icu) was not required.It was reported that not more than one vacuum-induced hemorrhage control system (jada system) was used.It was reported that after removal of vacuum-induced hemorrhage control system (jada system) it was not reinserted and there was hesitancy to open another one.It was unsure if there was invasive placenta.It was unknown if the vacuum-induced hemorrhage control system (jada system) was available for evaluation.The events of device placement issue and device ineffective were considered to be serious as it required intervention.Medical device reporting criteria: serious injury.(b)(4).
 
Manufacturer Narrative
Based on the information we have received, there is no indication that the device malfunctioned.The device is assembled according to specifications.In process and finished product testing are performed and approved prior to release.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
JADA SYSTEM
Type of Device
INTRAUTERINE VACUUM CONTRACTION SYSTEM
Manufacturer (Section D)
ORGANON & CO.
30 hudson street
jersey city NJ 07302
Manufacturer (Section G)
ORGANON & CO.
30 hudson street
jersey city NJ 07302
Manufacturer Contact
30 hudson street
jersey city, NJ 07302
MDR Report Key15870880
MDR Text Key304423419
Report Number3002806821-2022-00014
Device Sequence Number1
Product Code OQY
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
510K K201199
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 11/28/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received11/28/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient SexFemale
-
-